Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Glycosuria, Renal

Known as: Renal glycosuria, RENAL GLUCOSURIA, MUNUAISPERAINEN SOKERIVIRTSAISUUS 
An autosomal inherited disorder due to defective reabsorption of GLUCOSE by the PROXIMAL RENAL TUBULES. The urinary loss of glucose can reach beyond… Expand
National Institutes of Health

Related topics

Related topics

10 relations
Autosomal dominant inheritanceAutosomal recessive inheritanceIn BloodMicrobiological
Expand

Broader (1)

disorder of carbohydrate metabolism

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Abstract Background The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2… Expand
Highly Cited
2019
Highly Cited
2019
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
BACKGROUND The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium–glucose cotransporter 2 that… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Review
2018
Review
2018
Development of SGLT1 and SGLT2 inhibitors
Sodium–glucose cotransporters SGLT1 (encoded by SGLT1, also known as SLC5A1) and SGLT2 (encoded by SGLT2, also known as SLC5A2… Expand
  • figure 1
  • figure 2
Review
2018
Review
2018
Cardiovascular Effects of New Oral Glucose-Lowering Agents
  • A. Scheen
  • Circulation research
  • 2018
    • Corpus ID: 13692049
Cardiovascular disease (CVD) is a major challenge in the management of type 2 diabetes mellitus. Glucose-lowering agents that… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Review
2017
Review
2017
Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives
Inhibitors of the sodium‐glucose cotransporter SGLT2 are a new class of antihyperglycemic drugs that have been approved for the… Expand
Highly Cited
2014
Highly Cited
2014
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
Chronic hyperglycemia impairs insulin action, resulting in glucotoxicity, which can be ameliorated in animal models by inducing… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2008
Highly Cited
2008
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
OBJECTIVE Dapagliflozin, a novel inhibitor of renal sodium-glucose cotransporter 2, allows an insulin-independent approach to… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1994
Highly Cited
1994
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.
The major reabsorptive mechanism for D-glucose in the kidney is known to involve a low affinity high capacity Na+/glucose… Expand
  • figure 1
  • figure 2
  • figure 4
Highly Cited
1987
Highly Cited
1987
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
To assess the extent to which the progression of diabetic retinopathy can be arrested by improved glycemic control, 35 normal… Expand
  • table 1
  • table 2
  • figure 1
Highly Cited
1980
Highly Cited
1980
Breeding of a non-obese, diabetic strain of mice.
A female mouse spontaneously exhibiting polyuria and glucosuria accompanied by rapid weight loss waa found in one of two sublines… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE